Medicine and Dentistry
Diabetes Mellitus
81%
Cardiovascular System
66%
Diabetes
65%
Heart Failure
62%
Cognitive Defect
60%
COVID-19
58%
microRNA
56%
Cardiovascular Disease
53%
Arginine
50%
Frailty
43%
Endothelial Cell
38%
Cardiac Resynchronization Therapy
35%
Calcium Ion
35%
Acute Heart Infarction
33%
Montreal Cognitive Assessment
33%
Pathophysiology
33%
Adrenergic Receptor
32%
Physical Disease
31%
Impaired Glucose Tolerance
27%
Glycon
26%
Walking Speed
24%
Ryanodine Receptor
23%
Sodium Glucose Cotransporter 2 Inhibitor
23%
Disease
22%
Chronic Kidney Disease
22%
Maturity Onset Diabetes of the Young
22%
Skeletal Muscle
21%
Hyperglycemia
21%
Empagliflozin
21%
Heart Failure with Preserved Ejection Fraction
21%
Isotopes of Calcium
19%
Endothelial Function
19%
Myocardial Infarction
18%
Elderly (Age Groups)
18%
Patient with Diabetes
18%
Placebo
18%
Intracellular Calcium
17%
Endothelial Dysfunction
15%
Atrial Fibrillation
15%
Sympathetic Nervous System
15%
Insulin Resistance
15%
Oxidative Stress
15%
Panic Disorder
14%
ST Segment Elevation Myocardial Infarction
14%
Group Trial
14%
Diabetology
14%
Cohort Analysis
14%
Adrenergic System
14%
Interim Analysis
14%
Cognition
13%
Pharmacology, Toxicology and Pharmaceutical Science
Diabetes Mellitus
100%
Disease
94%
Heart Failure
88%
microRNA
80%
Cognitive Defect
58%
Coronavirinae
51%
Arginine
50%
Acute Heart Infarction
47%
Calcium Ion
44%
Frailty
42%
Adrenergic Receptor
37%
Sodium Glucose Cotransporter 2 Inhibitor
36%
Biological Marker
34%
G Protein Coupled Receptor Kinase 2
28%
Physical Disease
28%
Cardiovascular Disease
28%
Non Insulin Dependent Diabetes Mellitus
27%
Endothelial Dysfunction
25%
Heart Infarction
25%
Atrial Fibrillation
24%
Pandemic
23%
Receptor
23%
Pathophysiology
22%
Hyperglycemia
21%
Ischemia
20%
G Protein Coupled Receptor Kinase
19%
Phosphotransferase
17%
Metformin
17%
ST Segment Elevation Myocardial Infarction
16%
Symptom
15%
Placebo
15%
Inositol 1,4,5 Trisphosphate Receptor
15%
Randomized Clinical Trial
15%
Clinical Trial
15%
Malignant Neoplasm
14%
Heart Arrhythmia
14%
Cohort Study
14%
Sortilin
14%
Restenosis
14%
Thrombosis
14%
Heart Failure with Preserved Ejection Fraction
14%
Neurologic Disease
14%
microRNA 34a
14%
Binding Protein
14%
Empagliflozin
14%
Resistant Hypertension
14%
Chronic Kidney Failure
14%
Major Adverse Cardiac Event
14%
Heart Left Ventricle Hypertrophy
14%
Inflammation
14%
Keyphrases
Hypertension
59%
Arginine
50%
MicroRNA
49%
Functional Role
48%
Cardiovascular Disease
47%
Heart Failure
40%
Diabetes
39%
Adrenergic Receptors
34%
Acute Myocardial Infarction
30%
Diabetic Patients
29%
GRK2
28%
Cognitive Impairment
28%
Type 1 Diabetes Mellitus (T1DM)
28%
Hypertensive
27%
Atrial Fibrillation
26%
Pathophysiology
25%
Sodium-glucose Cotransporter 2 Inhibitors (SGLT2i)
23%
Inositol 1,4,5-trisphosphate Receptor (IP3R)
23%
COVID-19
23%
Frail Elderly
22%
Aging
22%
Endothelial Cells
21%
Adrenergic System
21%
Skeletal muscle
21%
Hypertensive Patients
20%
Oxidative Stress
19%
G Protein-coupled Receptor Kinase
19%
Endothelial Dysfunction
19%
Insulin Resistance
18%
Beneficial Effects
17%
Ca2+
17%
Calcium Release Channel
16%
Insulin Release
16%
Ryanodine Receptor
16%
Endothelial Function
16%
Myocardial Infarction
15%
Sortilin
14%
COVID-19 Pandemic
14%
Mitochondria
14%
Mechanistic Role
14%
MicroRNA-34a (miR-34a)
14%
Mitochondrial Fitness
14%
GRK5
14%
Frailty
13%
Sarcoplasmic Reticulum
13%
Metabolism
13%
Inflammation
13%
Sympathetic Nervous System
12%
Heart Failure Patients
12%
Overexpression
12%